Certified Reference Materials for Standardization of cfDNA Isolation Recovery in Liquid Biopsy
Standardized reference materials for blood cancer detection tests could make early screening more reliable and consistent across different labs worldwide.
This study created the first certified reference materials for standardizing cfDNA isolation in liquid biopsy, addressing a critical gap in pre-analytical quality control that affects early cancer detection assays. The CRMs enable fragment-length-resolved recovery assessment, supporting improved reliability and interlaboratory comparability of liquid biopsy tests.
What the study was
- Study design
- Reference material development and validation study
- Population
- Clinical and research laboratories performing cfDNA liquid biopsy
- Category
- Diagnostics
- Maturity
- Validated
- Journal
- The Journal of Molecular Diagnostics
Why it surfaced
First certified reference materials for cfDNA isolation standardization. Addresses a major pre-analytical bottleneck limiting liquid biopsy reliability. High novelty and near-term implementability for clinical labs performing ctDNA/cfDNA assays.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.